E. Barca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
E. Barca has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
A. Toscano
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
1 shared publicationC.M. Quinzii
Department of Neurology, Columbia University Medical Center, New York, NY, USA
1 shared publicationD. Nunnari
IRCCS Centro Neurolesi "Bonino Pulejo", Messina, Italy
1 shared publicationF. Montagnese
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
1 shared publication- Francesca Granata
Neuroradiology Unit, Biomorf Department, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy
1 shared publication - Lorenzo Peverelli
Medical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy
1 shared publication
Latest Publications
- 27 January 2016
- Published by Wiley in Clinical Genetics
- Vol. 90 (2) , 156-160
Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3
Inherited ataxias are a group of heterogeneous disorders in children or adults but their genetic definition remains still undetermined in almost half of the patients. However, CoQ10 deficiency is a rare cause of cerebellar ataxia and ADCK3 is the most frequent gene associated with this defect. We herein report a 48 year old man, who presented with dysarthria and walking difficulties. Brain magnetic resonance imaging showed a marked cerebellar atrophy. Serum lactate was elevated. Tissues obtained by muscle and skin biopsies were studied for biochemical and genetic characterization. Skeletal muscle biochemistry revealed decreased activities of complexes I+III and II+III and a severe reduction of CoQ10, while skin fibroblasts showed normal CoQ10 levels. A mild loss of maximal respiration capacity was also found by high‐resolution respirometry. Molecular studies identified a novel homozygous deletion (c.504del_CT) in ADCK3, causing a premature stop codon. Western blot analysis revealed marked reduction of ADCK3 protein levels. Treatment with CoQ10 was started and, after 1 year follow‐up, patient neurological condition slightly improved. This report suggests the importance of investigating mitochondrial function and, in particular, muscle CoQ10 levels, in patients with adult‐onset cerebellar ataxia. Moreover, clinical stabilization by CoQ10 supplementation emphasizes the importance of an early diagnosis.
- 27 January 2016
- Published by Wiley in Clinical Genetics
- Vol. 90 (2) , 156-160
Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3
Inherited ataxias are a group of heterogeneous disorders in children or adults but their genetic definition remains still undetermined in almost half of the patients. However, CoQ10 deficiency is a rare cause of cerebellar ataxia and ADCK3 is the most frequent gene associated with this defect. We herein report a 48 year old man, who presented with dysarthria and walking difficulties. Brain magnetic resonance imaging showed a marked cerebellar atrophy. Serum lactate was elevated. Tissues obtained by muscle and skin biopsies were studied for biochemical and genetic characterization. Skeletal muscle biochemistry revealed decreased activities of complexes I+III and II+III and a severe reduction of CoQ10, while skin fibroblasts showed normal CoQ10 levels. A mild loss of maximal respiration capacity was also found by high‐resolution respirometry. Molecular studies identified a novel homozygous deletion (c.504del_CT) in ADCK3, causing a premature stop codon. Western blot analysis revealed marked reduction of ADCK3 protein levels. Treatment with CoQ10 was started and, after 1 year follow‐up, patient neurological condition slightly improved. This report suggests the importance of investigating mitochondrial function and, in particular, muscle CoQ10 levels, in patients with adult‐onset cerebellar ataxia. Moreover, clinical stabilization by CoQ10 supplementation emphasizes the importance of an early diagnosis.